Acquired factor V inhibitor in a patient with a mechanical aortic valve under warfarin therapy

Intern Med. 2010;49(20):2229-33. doi: 10.2169/internalmedicine.49.4042. Epub 2010 Oct 15.

Abstract

An 84-year-old woman under warfarin therapy, who had undergone mechanical valve replacement 29 months previously, developed coagulation abnormalities after antibiotic treatment for pyelonephritis. Laboratory findings included PT at 47.6 sec, activated thromboplastin time (APTT) at 147 sec, factor V (FV) activity of 4% and FV inhibitor of 8 BU. Although overt bleeding was not observed, administration of prednisolone was started. Her coagulation abnormalities were rapidly normalized. It was later determined that the patient had received bovine thrombin at surgery. The presence of a FV inhibitor should be considered in the differential diagnosis in patients demonstrating an unexpected prolongation of PT under warfarin therapy following surgery.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Anticoagulants / therapeutic use*
  • Aortic Valve Stenosis / surgery
  • Aortic Valve*
  • Cattle
  • Ceftriaxone / therapeutic use
  • Factor V / immunology*
  • Female
  • Heart Valve Prosthesis*
  • Hemorrhagic Disorders / drug therapy
  • Hemorrhagic Disorders / etiology*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Partial Thromboplastin Time
  • Postoperative Complications / drug therapy
  • Postoperative Complications / etiology*
  • Prednisolone / therapeutic use
  • Prothrombin Time
  • Pyelonephritis / complications
  • Pyelonephritis / drug therapy
  • Species Specificity
  • Thrombin / adverse effects*
  • Thrombin / immunology
  • Warfarin / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Anticoagulants
  • Immunosuppressive Agents
  • Warfarin
  • Ceftriaxone
  • Factor V
  • Prednisolone
  • Thrombin